CIK 0000064803 · Large accelerated filer
CVS HEALTH Corp
Sign in to watch- Ticker
- CVS
- Exchange
- NYSE
- Industry
- Retail-Drug Stores and Proprietary Stores
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 050494040
- Phone
- 4017651500
- Business address
- ONE CVS DR., WOONSOCKET, RI, 02895
- Former names
- CVS CAREMARK CORP, CVS/CAREMARK CORP, CVS CORP, MELVILLE CORP
- Open-market buys, last 90 days
- $2,001,315
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$2,001,315. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-06 | Shah Prem S EVP and Group President | Purchase | +23,855 | $83.90 | $2.0M | 88,516.16 |
| 2026-06-26 | Clark James David SVP, Cont & Chief Acct Officer | Shares withheld for taxes | −454 | $90.98 | $41K | 27,606 |
| 2026-05-31 | Newman Brian EVP, Chief Financial Officer | Shares withheld for taxes | −2,478 | $90.98 | $225K | 3,008 |
| 2026-05-31 | Compton-Phillips Amy EVP, Chief Medical Officer | Shares withheld for taxes | −7,618 | $90.98 | $693K | 9,557 |
| 2026-05-21 | AGUIRRE FERNANDO Director | Returned to the company | −1,563 | $93.50 | $146K | 10,513 |
| 2026-05-21 | ROBBINS LARRY Director | Sale | −370,462 | $93.45 | $34.6M | 4,824,799 |
| 2026-05-21 | ROBBINS LARRY Director | Sale · Cash-Settled Swaps | −378,000 | $93.31 | $35.3M | 0 |
| 2026-05-20 | AGUIRRE FERNANDO Director | Returned to the company | −30,437 | $93.78 | $2.9M | 12,076 |
| 2026-05-20 | ROBBINS LARRY Director | Sale | −797,628 | $93.48 | $74.6M | 5,415,633 |
| 2026-05-20 | ROBBINS LARRY Director | Sale | −152,691 | $94.81 | $14.5M | 5,262,942 |
| 2026-05-20 | ROBBINS LARRY Director | Sale | −66,881 | $95.67 | $6.4M | 5,196,061 |
| 2026-05-20 | ROBBINS LARRY Director | Sale | −800 | $96.28 | $77K | 5,195,261 |
| 2026-05-19 | ROBBINS LARRY Director | Sale | −1,983,387 | $94.45 | $187.3M | 6,213,412 |
| 2026-05-19 | ROBBINS LARRY Director | Sale | −151 | $95.18 | $14K | 6,213,261 |
| 2026-05-14 | Gallina John E Director | Grant or award · Deferred Stock Units | +1,447.5 | $97.15 | $141K | 1,447.5 |
| 2026-05-14 | Mahoney Michael F Director | Grant or award · Deferred Stock Units | +1,737 | $97.15 | $169K | 6,428.82 |
| 2026-05-14 | AGUIRRE FERNANDO Director | Grant or award | +1,563 | $97.15 | $152K | 42,513 |
| 2026-05-14 | Balser Jeffrey R. Director | Grant or award | +2,058 | $97.15 | $200K | 15,717 |
| 2026-05-14 | KIRBY J SCOTT Director | Grant or award | +1,447 | $97.15 | $141K | 14,434 |
| 2026-05-14 | Norwalk Leslie V Director | Grant or award | +1,447 | $97.15 | $141K | 7,376 |
Page 1 of 15 · 283 trades